Clinical experiences with antimonyl-dimethylcysteino-tartrate (NAP) in a rural population infected with Schistosoma mansoni.
D000293:Adolescent; D000328:Adult; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use*; D000965:Antimony / Q000009:adverse effects / Q000627:therapeutic use*; D003545:Cysteine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012552:Schistosomiasis / Q000188:drug therapy*; D012737:Sex Factors; D013644:Tartrates / Q000009:adverse effects / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D000871:Anthelmintics; D013644:Tartrates; D000965:Antimony; D003545:Cysteine